COMPASS Pathways plc (CMPS) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

COMPASS Pathways plc (CMPS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

Engineers Gate Manager LP lessened its holdings in Compass Pathways PLC Sponsored ADR (NASDAQ: CMPS)

ATLANTA--(BUSINESS WIRE)--Strata Mental Health Solutions, the expert-led training and implementation

New certificate program will prepare clinicians to support patients receiving COMP360 psilocybin tre

These programs are intended to address both the need for foundational training in psychedelics, as w

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

CMPS is testing a breakout after positive Phase 3 data, with a close above $15.40 potentially openin

Compass Pathways surges 11% after COMP360 Phase 3 trial shows durable 52-week relief for treatment-r

Compass Pathways (NASDAQ:CMPS) climbed 4% on Wednesday after new 52-week data from the company's Pha

Compass Pathways (NASDAQ:CMPS) climbed 4% on Wednesday after new 52-week data from the company's Pha

Notable additional benefit observed with an added reduction in MADRS1 score leading to an average 13

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

https://www.bloomberg.com/news/articles/2026-09-08/fda-s-acting-drug-vaccine-regulators-tapped-for-p

Congress taking place in New Orleans, LA, from September 14-19. The Company will debut Change the Tu

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways, a biotechnology company ded

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotec

Compass Pathways plc is rated Strong Buy with a $25–$30 fair value, reflecting a significant upside

COMPASS Pathways remains a Buy, but Eli Lilly's acquisition of AtaiBeckley narrows CMPS's long-term

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Compass Pathways NASDAQ: CMPS said it remains on track to complete a new drug application for COMP36

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Compass Pathways (NASDAQ:CMPS) with

Morgan Stanley analyst Judah Frommer maintains Compass Pathways (NASDAQ:CMPS) with a Overweight a

RBC Capital analyst Leonid Timashev maintains Compass Pathways (NASDAQ:CMPS) with a Outperform an

B. Riley Securities analyst Madison El-Saadi maintains Compass Pathways (NASDAQ:CMPS) with a Buy

The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-

Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(0.36) per share which beat the analyst

Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(1.88) per share which missed the analy

Wells Fargo analyst Benjamin Burnett initiates coverage on Compass Pathways (NASDAQ:CMPS) with a

Robinhood Markets Inc. (NASDAQ: HOOD) stock declines on Thursday due to tech market pullbacks, recen

Cathie Wood sold $10M of Robinhood while adding $15M to SpaceX and boosting Archer Aviation. Here&#3

BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. R

GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea

Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring a

JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Compass Pathways (NASDAQ:CMPS) wit

Evercore ISI Group analyst Gavin Clark-Gartner upgrades Compass Pathways (NASDAQ:CMPS) from In-Li

Stifel analyst Paul Matteis maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the pr

Morgan Stanley analyst Judah Frommer reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight

Oppenheimer analyst Francois Brisebois reiterates Compass Pathways (NASDAQ:CMPS) with a Outperfor

BTIG analyst Thomas Shrader maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the pr

Compass Pathways reported positive 26-week Phase 3 COMP360 data for treatment-resistant depression a

New 6-month data supports COMP360’s potential to establish a new standard of care in TRDData from po

Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and